PDE4A and early-onset autosomal dominant Alzheimer disease: Currently, there are some PDE4 inhibitors in clinical trials for different neurological disorders (Table 4) such as Alzheimer’s disease (AD), fragile X syndrome, depression and Huntington’s disease [23].